Company Overview and News

Maharashtra ryots to get funds, support

2017-08-17 thehindubusinessline
The 2030 Water Resources Group (2030WRG), a consortium of public and private sector entities under the International Finance Corporation (IFC) will be raising up to $10 million to help about four lakh cotton farmers in Maharashtra adopt sustainable water and agriculture practices. It is talking to global corporates and textile players such as H&M and Marks & Spencer to raise funds.
Upvote Downvote

Maharashtra launches joint platform to address water resources crunch

Mumbai: In a bid to address the critical water resources challenges in Maharashtra, the state government and 2030 Water Resources Group (WRG) launched the Maharashtra Water Resources ‘Multi-Stakeholder Platform’ (Maharashtra Water – MSP), a project which is expected to attract a funding of around USD one billion.
Upvote Downvote

Water Resources Group Ltd tops ASX % Gainers in morning trade

Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.
Upvote Downvote

Water-energy-food: can leaders at Davos solve this global conundrum? | Dominic Waughray | Global Development Professionals Network | The Guardian

2017-01-16 theguardian
Huge demands for water present complicated challenges, but leaders will not resolve these kinds of interconnected risks without a systems approach
Upvote Downvote

Water Resources Group to begin field trials of ozone generator

The Australia-based company is focused on developing water treatment solutions, specifically the Air2O3 generator which is an ozone generator used for treating water. The objective of the trials will be to validate the performance of Air2O3 in typical operating conditions and will be managed by an established supplier of water treatment systems. The testing for a specific market application will commence in January and continue for several weeks.
Upvote Downvote

The Most Important Commodity Investors Can't Trade And Its Growing Demand

2016-10-31 seekingalpha
One third of the world's population will live in areas with more than a 50% water deficit.
Upvote Downvote

Market Update

Upvote Downvote

Appendix 4D

Upvote Downvote

Appendix 4C

Upvote Downvote

Results of Meeting

Upvote Downvote

Appendix 4G

Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN:, Inc Analysis and Research Report

2018-04-25 - Asif

Overview opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...